Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;106(1):18-24.
doi: 10.1016/j.ymgme.2012.02.015. Epub 2012 Mar 8.

Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies

Affiliations
Review

Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies

Autumn L Fletcher et al. Mol Genet Metab. 2012 May.

Abstract

Although the retina is thought to primarily rely on glucose for fuel, inherited deficiency of one or more activities of mitochondrial trifunctional protein results in a pigmentary retinopathy leading to vision loss. Many other enzymatic deficiencies in fatty acid oxidation pathways have been described, none of which results in retinal complications. The etiology of retinopathy among patients with defects in trifunctional protein is unknown. Trifunctional protein is a heteroctomer; two genes encode the alpha and beta subunits of TFP respectively, HADHA and HADHB. A common mutation in HADHA, c.1528G>C, leads to a single amino acid substitution, p. Glu474Gln, and impairs primarily long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) activity leading to LCHAD deficiency (LCHADD). Other mutations in HADHA or HADHB often lead to significant reduction in all three enzymatic activities and result in trifunctional protein deficiency (TFPD). Despite many similarities in clinical presentation and phenotype, there is growing evidence that they can result in different chronic complications. This review will outline the clinical similarities and differences between LCHADD and TFPD, describe the course of the associated retinopathy, propose a genotype/phenotype correlation with the severity of retinopathy, and discuss the current theories about the etiology of the retinopathy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a. Pathway of long-chain fatty acid oxidation with blocked activities of TFP and blocked dehydrogenase step and the respective metabolite build up illustrated. b. A cartoon illustration of TFP with subunits and activities labeled.
Fig. 2
Fig. 2
a) Normal retinal photograph; b) patient with stage 2 chorioretinopathy of LCHADD, c) patient with stage 4 chorioretinopathy of LCHADD; d) same eye as pictured in panel c illustrating peripheral progression of stage 4 chorioretinopathy.
Fig. 3
Fig. 3
ERG waveforms of two age and test condition matched subjects compared to a normal control 30 Hz Flicker and photopic single flash = cone-driven response; scotopic Ops, scotopic single flash = rod-driven response. Patient 4 has lower amplitude and increased implicit time representing rod/cone dysfunction compared to patient 5 and the normal control.

References

    1. Tyni T, Johnson M, Eaton S, Pourfarzam M, Andrews R, Turnbull DM. Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium. Pediatr. Res. 2002;52:595–600. - PubMed
    1. Gillingham MB, Weleber RG, Neuringer M, Connor WE, Mills M, van Calcar S, Ver Hoeve J, Wolff J, Harding CO. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol. Genet. Metab. 2005;86:124–133. - PMC - PubMed
    1. Berman E. Biochemistry of the Eye. New York: Plenum Press; 1991.
    1. Ushikubo S, Aoyama T, Kamijo T, Wanders RJ, Rinaldo P, Vockley J, Hashimoto T. Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits. Am. J. Hum. Genet. 1996;58:979–988. - PMC - PubMed
    1. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu. Rev. Physiol. 2002;64:477–502. - PubMed

Publication types

MeSH terms

Substances